Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

7.57
+0.34004.70%
Post-market: 7.570.00000.00%19:19 EST
Volume:1.09M
Turnover:8.24M
Market Cap:447.36M
PE:-5.25
High:7.72
Open:7.37
Low:7.30
Close:7.23
52wk High:9.60
52wk Low:3.81
Shares:59.10M
Float Shares:49.48M
Volume Ratio:1.01
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4426
EPS(LYR):-0.3300
ROE:-16.72%
ROA:-12.15%
PB:0.96
PE(LYR):-22.94

Loading ...

Vanda Pharmaceuticals Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Feb 05

Vanda Pharmaceuticals Advances Ponesimod Into Phase 3 Psoriasis Study: What Investors Should Know

TIPRANKS
·
Jan 24

BUZZ-U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, Gap

Reuters
·
Jan 09

H.C. Wainwright says rejection of Vanda’s tasimelteon ‘only minor setback’

TIPRANKS
·
Jan 08

BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, Nike

Reuters
·
Jan 08

Shares of Vanda Pharmaceuticals Drop Almost 12% Premarket After U.S. FDA Rejects Jet Lag Drug Application

THOMSON REUTERS
·
Jan 08

BUZZ-Vanda falls as US FDA rejects jet lag drug application

Reuters
·
Jan 08

Vanda Pharmaceuticals down 11% to $7.55 after FDA rejects sNDA for hetlioz

TIPRANKS
·
Jan 08

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on Hetlioz® Supplemental New Drug Application for Jet Lag Disorder

THOMSON REUTERS
·
Jan 08

Vanda Pharmaceuticals Inc - FDA Finds Insufficient Evidence for Hetlioz Effectiveness in Jet Lag

THOMSON REUTERS
·
Jan 08

Vanda Pharmaceuticals Inc - FDA Does Not Approve Hetlioz for Jet Lag Disorder

THOMSON REUTERS
·
Jan 08

FDA Approves Vanda Pharma Motion Sickness Drug, Fuels Upside

Benzinga_recent_news
·
Jan 07

Vanda Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 05

Vanda Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $22 From $20

THOMSON REUTERS
·
Jan 05

S&P 500 Falls For Fourth Session But Records Gains In 2025: Investor Sentiment Declines, Fear & Greed Index Remains In 'Neutral Zone

Benzinga_recent_news
·
Jan 02

BUZZ-U.S. STOCKS ON THE MOVE-Oil producers, media stocks, US transport stocks, US airlines

Reuters
·
Jan 01

Vanda Pharmaceuticals Up Over 34%, on Pace for Largest Percent Increase Since November 2013 -- Data Talk

Dow Jones
·
Jan 01

U.S. Stock Movement: Anti-Nausea Drug Nereus Receives FDA Approval, Vanda Pharmaceuticals (VNDA.US) Surges Over 32%

Stock News
·
Dec 31, 2025

These Stocks Are Moving the Most Today: Nvidia, Tesla, Hecla, Newmont, Nike, Vanda, Corcept, DJT, and More -- Barrons.com

Dow Jones
·
Dec 31, 2025

Vanda Pharmaceuticals Inc : B. Riley Raises Target Price to $14 From $11

THOMSON REUTERS
·
Dec 31, 2025